AAAAAA

   
Results: 1-25 | 26-38
Results: 1-25/38
STATISTICAL ISSUES FOR HIV SURROGATE END-POINTS - POINT COUNTERPOINT/
Authors: ALBERT JM IOANNIDIS JPA REICHELDERFER P CONWAY B COOMBS RW CRANE L DEMASI R DIXON DO FLANDRE P HUGHES MD KALISH LA LARNTZ K LIN DY MARSCHNER IC MUNOZ A MURRAY J NEATON J PETTINELLI C RIDA W TAYLOR JMG WELLES SL
Citation: Jm. Albert et al., STATISTICAL ISSUES FOR HIV SURROGATE END-POINTS - POINT COUNTERPOINT/, Statistics in medicine, 17(21), 1998, pp. 2435-2462
CD4 CELL COUNT AS A SURROGATE END-POINT IN HIV CLINICAL-TRIALS - A METAANALYSIS OF STUDIES OF THE AIDS CLINICAL-TRIALS GROUP
Authors: HUGHES MD DANIELS MJ FISCHL MA KIM S SCHOOLEY RT
Citation: Md. Hughes et al., CD4 CELL COUNT AS A SURROGATE END-POINT IN HIV CLINICAL-TRIALS - A METAANALYSIS OF STUDIES OF THE AIDS CLINICAL-TRIALS GROUP, AIDS, 12(14), 1998, pp. 1823-1832
CCRS TRIANGLE-CCR5 HETEROZYGOSITY - A SELECTIVE PRESSURE FOR THE SYNCYTIUM-INDUCING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PHENOTYPE/
Authors: DAQUILA RT SUTTON L SAVARA A HUGHES MD JOHNSON VA
Citation: Rt. Daquila et al., CCRS TRIANGLE-CCR5 HETEROZYGOSITY - A SELECTIVE PRESSURE FOR THE SYNCYTIUM-INDUCING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PHENOTYPE/, The Journal of infectious diseases, 177(6), 1998, pp. 1549-1553
VARIABILITY AND PROGNOSTIC VALUES OF VIROLOGICAL AND CD4 CELL MEASURES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-INFECTED PATIENTS WITH 200-500 CD4 CELLS MM(3) (ACTG-175)/
Authors: LATHEY JL HUGHES MD FISCUS SA PI T JACKSON JB RASHEED S ELBEIK T REICHMAN R JAPOUR A DAQUILA RT SCOTT W GRIFFITH BP HAMMER SM KATZENSTEIN DA
Citation: Jl. Lathey et al., VARIABILITY AND PROGNOSTIC VALUES OF VIROLOGICAL AND CD4 CELL MEASURES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-INFECTED PATIENTS WITH 200-500 CD4 CELLS MM(3) (ACTG-175)/, The Journal of infectious diseases, 177(3), 1998, pp. 617-624
CHANGES IN VIROLOGICAL MARKERS AS PREDICTORS OF CD4 CELL DECLINE AND PROGRESSION OF DISEASE IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTEDADULTS TREATED WITH NUCLEOSIDES
Authors: FISCUS SA HUGHES MD LATHEY JL PI T JACKSON JB RASHEED S ELBEIK T REICHMAN R JAPOUR A BYINGTON R SCOTT W GRIFFITH BP KATZENSTEIN DA HAMMER SM
Citation: Sa. Fiscus et al., CHANGES IN VIROLOGICAL MARKERS AS PREDICTORS OF CD4 CELL DECLINE AND PROGRESSION OF DISEASE IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTEDADULTS TREATED WITH NUCLEOSIDES, The Journal of infectious diseases, 177(3), 1998, pp. 625-633
USE OF CHANGES IN PLASMA-LEVELS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA TO ASSESS THE CLINICAL BENEFIT OF ANTIRETROVIRAL THERAPY
Authors: MARSCHNER IC COLLIER AC COOMBS RW DAQUILA RT DEGRUTTOLA V FISCHL MA HAMMER SM HUGHES MD JOHNSON VA KATZENSTEIN DA RICHMAN DD SMEATON LM SPECTOR SA SAAG MS
Citation: Ic. Marschner et al., USE OF CHANGES IN PLASMA-LEVELS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA TO ASSESS THE CLINICAL BENEFIT OF ANTIRETROVIRAL THERAPY, The Journal of infectious diseases, 177(1), 1998, pp. 40-47
POPULATION PHARMACOKINETICS OF NEVIRAPINE, ZIDOVUDINE AND DIDANOSINE AFTER COMBINATION THERAPY IN HIV-INFECTED PATIENTS
Authors: ZHOU XJ SHEINER LB DAQUILA RT HUGHES MD HIRSCH MS FISCHL MA JOHNSON VA MYERS M SOMMADOSSI JP
Citation: Xj. Zhou et al., POPULATION PHARMACOKINETICS OF NEVIRAPINE, ZIDOVUDINE AND DIDANOSINE AFTER COMBINATION THERAPY IN HIV-INFECTED PATIENTS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 39-39
PREDICTORS AND IMPACT OF PATIENTS LOST TO FOLLOW-UP IN A LONG-TERM RANDOMIZED TRIAL OF IMMEDIATE VERSUS DEFERRED ANTIRETROVIRAL TREATMENT
Authors: IOANNIDIS JPA BASSETT R HUGHES MD VOLBERDING PA SACKS HS LAU J
Citation: Jpa. Ioannidis et al., PREDICTORS AND IMPACT OF PATIENTS LOST TO FOLLOW-UP IN A LONG-TERM RANDOMIZED TRIAL OF IMMEDIATE VERSUS DEFERRED ANTIRETROVIRAL TREATMENT, Journal of acquired immune deficiency syndromes and human retrovirology, 16(1), 1997, pp. 22-30
INTRAHOUSEHOLD ALLOCATION OF ENERGY-INTAKE AMONG CHILDREN UNDER 5 YEARS AND THEIR PARENTS IN RURAL BANGLADESH
Authors: KRAMER EM PETERSON KE ROGERS BL HUGHES MD
Citation: Em. Kramer et al., INTRAHOUSEHOLD ALLOCATION OF ENERGY-INTAKE AMONG CHILDREN UNDER 5 YEARS AND THEIR PARENTS IN RURAL BANGLADESH, European journal of clinical nutrition, 51(11), 1997, pp. 750-756
PEAK FLOW VARIATION IN CHILDHOOD ASTHMA - RELATIONSHIP TO SYMPTOMS, ATOPY, AIRWAYS OBSTRUCTION AND HYPERRESPONSIVENESS
Authors: BRAND PLP DUIVERMAN EJ POSTMA DS WAALKENS HJ KERREBIJN KF VANESSENZANDVLIET EEM QUANJER PH SLUITER HJ POUW EM SCHOONBROOD DFME ROOS CM JANSEN HM DEGOOIJER A KERSTJENS HAM VANDERMARK TW KOETER GH DEJONG PM STERK PJ WEAVER AMJ DIJKMAN JH DEKHUIJZEN PNR FOLGERING HTM VANHERWAARDEN CLA OVERBEEK SE BOGAARD JM HILVERING C GANS SJ MENGELERS HJJ VANDERBRUGGENBOGAARTS BAHA KREUKNIET J KOUWENBERG JM PRINSEN JE GERRITSEN J KNOL K DEMONCHY JGR DEKKER FW KAPTEIN AA MERKUS PJFM POCOCK SJ HUGHES MD ROBINSON NJ BLEECKER ER MEYERS DA
Citation: Plp. Brand et al., PEAK FLOW VARIATION IN CHILDHOOD ASTHMA - RELATIONSHIP TO SYMPTOMS, ATOPY, AIRWAYS OBSTRUCTION AND HYPERRESPONSIVENESS, The European respiratory journal, 10(6), 1997, pp. 1242-1247
ALPHA-1-ANTITRYPSIN REPLACEMENT THERAPY - WILL ITS EFFICACY EVER BE PROVED
Authors: HUTCHISON DCS HUGHES MD
Citation: Dcs. Hutchison et Md. Hughes, ALPHA-1-ANTITRYPSIN REPLACEMENT THERAPY - WILL ITS EFFICACY EVER BE PROVED, The European respiratory journal, 10(10), 1997, pp. 2191-2193
EVALUATION OF THE BOTULISM HAZARD FROM VEGETABLES IN MODIFIED ATMOSPHERE PACKAGING
Authors: LARSON AE JOHNSON EA BARMORE CR HUGHES MD
Citation: Ae. Larson et al., EVALUATION OF THE BOTULISM HAZARD FROM VEGETABLES IN MODIFIED ATMOSPHERE PACKAGING, Journal of food protection, 60(10), 1997, pp. 1208-1214
POWER CONSIDERATIONS FOR CLINICAL-TRIALS USING MULTIVARIATE TIME-TO-EVENT DATA
Authors: HUGHES MD
Citation: Md. Hughes, POWER CONSIDERATIONS FOR CLINICAL-TRIALS USING MULTIVARIATE TIME-TO-EVENT DATA, Statistics in medicine, 16(8), 1997, pp. 865-882
METAANALYSIS FOR THE EVALUATION OF POTENTIAL SURROGATE MARKERS
Authors: DANIELS MJ HUGHES MD
Citation: Mj. Daniels et Md. Hughes, METAANALYSIS FOR THE EVALUATION OF POTENTIAL SURROGATE MARKERS, Statistics in medicine, 16(17), 1997, pp. 1965-1982
A CONTROLLED TRIAL OF 2 NUCLEOSIDE ANALOGS PLUS INDINAVIR IN PERSONS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND CD4 CELL COUNTS OF 200PER CUBIC MILLIMETER OR LESS
Authors: HAMMER SM SQUIRES KE HUGHES MD GRIMES JM DEMETER LM CURRIER JS ERON JJ FEINBERG JE BALFOUR HH DAYTON LR CHODAKEWITZ JA FISCHL MA
Citation: Sm. Hammer et al., A CONTROLLED TRIAL OF 2 NUCLEOSIDE ANALOGS PLUS INDINAVIR IN PERSONS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND CD4 CELL COUNTS OF 200PER CUBIC MILLIMETER OR LESS, The New England journal of medicine, 337(11), 1997, pp. 725-733
NEUROMUSCULAR FUNCTION IN HIV-INFECTION - ANALYSIS OF A PLACEBO-CONTROLLED COMBINATION ANTIRETROVIRAL TRIAL
Authors: SIMPSON DM KATZENSTEIN DA HAMMER SM HUGHES MD WILIAMSON D JIANG Q PI JT
Citation: Dm. Simpson et al., NEUROMUSCULAR FUNCTION IN HIV-INFECTION - ANALYSIS OF A PLACEBO-CONTROLLED COMBINATION ANTIRETROVIRAL TRIAL, Neurology, 48(3), 1997, pp. 66001-66001
ASSESSING THE EFFECTS OF INTERVENTIONS USING LONGITUDINAL DATA WITH SAMPLES SUBJECT TO SELECTION
Authors: LIN HM HUGHES MD
Citation: Hm. Lin et Md. Hughes, ASSESSING THE EFFECTS OF INTERVENTIONS USING LONGITUDINAL DATA WITH SAMPLES SUBJECT TO SELECTION, Biometrics, 53(3), 1997, pp. 924-936
MONITORING PLASMA HIV-1 RNA LEVELS IN ADDITION TO CD4(+) LYMPHOCYTE COUNT IMPROVES ASSESSMENT OF ANTIRETROVIRAL THERAPEUTIC RESPONSE
Authors: HUGHES MD JOHNSON VA HIRSCH MS BREMER JW ELBEIK T ERICE A KURITZKES DR SCOTT WA SPECTOR SA BASGOZ N FISCHL MA DAQUILA RT
Citation: Md. Hughes et al., MONITORING PLASMA HIV-1 RNA LEVELS IN ADDITION TO CD4(+) LYMPHOCYTE COUNT IMPROVES ASSESSMENT OF ANTIRETROVIRAL THERAPEUTIC RESPONSE, Annals of internal medicine, 126(12), 1997, pp. 929-938
ANALYSIS OF UNCONTROLLED TREATMENT CHANGES IN HIV CLINICAL-TRIALS
Authors: LIN HM HUGHES MD
Citation: Hm. Lin et Md. Hughes, ANALYSIS OF UNCONTROLLED TREATMENT CHANGES IN HIV CLINICAL-TRIALS, Statistics in medicine, 15(19), 1996, pp. 2053-2067
A TRIAL COMPARING NUCLEOSIDE MONOTHERAPY WITH COMBINATION THERAPY IN HIV-INFECTED ADULTS WITH CD4 CELL COUNTS FROM 200 TO 500 PER CUBIC MILLIMETER
Authors: HAMMER SM KATZENSTEIN DA HUGHES MD GUNDACKER H SCHOOLEY RT HAUBRICH RH HENRY WK LEDERMAN MM PHAIR JP NIU M HIRSCH MS MERIGAN TC BLASCHKE TF SIMPSON D MCLAREN C ROONEY J SALGO M
Citation: Sm. Hammer et al., A TRIAL COMPARING NUCLEOSIDE MONOTHERAPY WITH COMBINATION THERAPY IN HIV-INFECTED ADULTS WITH CD4 CELL COUNTS FROM 200 TO 500 PER CUBIC MILLIMETER, The New England journal of medicine, 335(15), 1996, pp. 1081-1090
THE RELATION OF VIROLOGICAL AND IMMUNOLOGICAL MARKERS TO CLINICAL OUTCOMES AFTER NUCLEOSIDE THERAPY IN HIV-INFECTED ADULTS WITH 200 TO 500 CD4 CELLS PER CUBIC MILLIMETER
Authors: KATZENSTEIN DA HAMMER SM HUGHES MD GUNDACKER H JACKSON JB FISCUS S RASHEED S ELBEIK T REICHMAN R JAPOUR A MERIGAN TC HIRSCH MS
Citation: Da. Katzenstein et al., THE RELATION OF VIROLOGICAL AND IMMUNOLOGICAL MARKERS TO CLINICAL OUTCOMES AFTER NUCLEOSIDE THERAPY IN HIV-INFECTED ADULTS WITH 200 TO 500 CD4 CELLS PER CUBIC MILLIMETER, The New England journal of medicine, 335(15), 1996, pp. 1091-1098
IS DELAYED INTRODUCTION OF INHALED CORTICOSTEROIDS HARMFUL IN PATIENTS WITH OBSTRUCTIVE AIRWAYS DISEASE (ASTHMA AND COPD)
Authors: OVERBEEK SE KERSTJENS HAM BOGAARD JM MULDER PGH POSTMA DS KERREBIJN KF QUANJER PH SLUITER HJ POUW EM SCHOONBROOD DFME ROOS CH JANSEN HM BRAND PLP DEGOOIJER A VANDERMARK TW KOETER GH DEJONG PM STERK PJ WEVER AMJ DIJKMAN JH DEKHUIJZEN PNR FOLGERING H VANHERWAARDEN CLA HILVERING C MENGELERS SJ GANS SJ VANDERBRUGGEN B KREUKNIET J VANESSENZANDVLIET EEM DUIVERMAN EJ KOUWENBERG JM PRINSEN JE WAALKENS HJ GERRITSEN J KNOL K DEMONCHY JGR KAPTEIN AA DEKKER FW MERKUS PJFM HUGHES MD ROBINSON NJ POCOCK SJ BLEECKER ER MEYERS DA
Citation: Se. Overbeek et al., IS DELAYED INTRODUCTION OF INHALED CORTICOSTEROIDS HARMFUL IN PATIENTS WITH OBSTRUCTIVE AIRWAYS DISEASE (ASTHMA AND COPD), Chest, 110(1), 1996, pp. 35-41
OPTIMAL SEQUENTIAL SCREENING GUIDELINES FOR QUANTITATIVE RISK-FACTORSMEASURED WITH ERROR
Authors: HUGHES MD THOMPSON SG POCOCK SJ
Citation: Md. Hughes et al., OPTIMAL SEQUENTIAL SCREENING GUIDELINES FOR QUANTITATIVE RISK-FACTORSMEASURED WITH ERROR, Journal of the American Statistical Association, 90(429), 1995, pp. 19-26
EVALUATING SURROGATE MARKERS
Authors: HUGHES MD DEGRUTTOLA V WELLES SL
Citation: Md. Hughes et al., EVALUATING SURROGATE MARKERS, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 1-8
IMPORTANCE OF TOTAL SERUM IGE FOR IMPROVEMENT IN AIRWAYS HYPERRESPONSIVENESS WITH INHALED CORTICOSTEROIDS IN ASTHMA AND CHRONIC OBSTRUCTIVEPULMONARY-DISEASE
Authors: KERSTJENS HAM SCHOUTEN JP BRAND PLP SCHOONBROOD DFME STERK PJ POSTMA DS KERREBIJN KF QUANJER PH SLUITER HJ POUW EM ROOS CM JANSEN HM DEGOOYER A VANDERMARK TW KOETER GH DELONG PM WEVER AMJ DIJKMAN JH DEKHUIJZEN PNR FOLGERING HTM VANHERWAARDEN CLA OVERBEEK SE BOGAARD JM HILVERING C GANS SJ MENGELEERS HJJ VANDERBRUGGENBOGAARTS BAHA KREUKNIET J VANESSENZANDVLIET EEM DUIVERMAN EJ KOUWENBERG JM PRINSEN JE WAALKENS HJ GERRITSEN J KNOL K DEMONCHY JGR DEKKER FW KAPTEIN AA MERKUS PJFM POCOCK SJ HUGHES MD ROBINSON NJ BLEECKER ER MEYERS DA
Citation: Ham. Kerstjens et al., IMPORTANCE OF TOTAL SERUM IGE FOR IMPROVEMENT IN AIRWAYS HYPERRESPONSIVENESS WITH INHALED CORTICOSTEROIDS IN ASTHMA AND CHRONIC OBSTRUCTIVEPULMONARY-DISEASE, American journal of respiratory and critical care medicine, 151(2), 1995, pp. 360-368
Risultati: 1-25 | 26-38